Literature DB >> 3463170

Studies of eicosanoid production in the air pouch model of synovial inflammation.

A D Sedgwick, P Lees.   

Abstract

The time course of the inflammatory reaction in the rat air pouch model of synovial inflammation has been investigated at different stages of development of the lining structure using immune (pertussis vaccine) and non-immune (carrageenan) irritants. Exudate volumes and leucocyte numbers were greater with carrageenan than with pertussis vaccine but with both irritants much greater reactions were obtained when the irritant was injected at a time when the air pouch architecture most closely resembled synovium (i.e. 6 days). The time course of fluid accumulation following carrageenan in 6 day pouches was not interrupted when exudate was aspirated from the pouch six days after carrageenan injection. In the 6 day old air pouch PGE2 and 6-oxo-PGF1 alpha concentration peaked at 6 hours and 24 hours respectively. With carrageenan and pertussis vaccine stimulation, LTB4 concentrations were maximal at 3-6 hours with both irritants and low concentrations were still present at 13 days. The presence of a lining structure was found to influence concentrations of PGE2 in the air pouch. Pre-treatment with colchicine or 5-fluorouracil to reduce cell accumulation was not found to effect the modified PGE2 response. Our findings suggest that the presence of a synovial like lining structure may induce changes in composition in respect to cellular content and in putative mediator concentrations. We conclude that it is important in elucidating the mechanisms involved in arthritic inflammation to study injury in a cavity lined by macrophages and fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3463170     DOI: 10.1007/BF01965008

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  19 in total

1.  Leucocyte migration and lysosomal enzymes release in rat carrageenin pleurisy.

Authors:  G Ammendola; M Di Rosa; L Sorrentino
Journal:  Agents Actions       Date:  1975-08

2.  Pertussis vaccine pleurisy: a model of delayed hypersensitivity.

Authors:  P A Dieppe; D A Willoughby; E C Huskisson; E Arrigoni-Martelli
Journal:  Agents Actions       Date:  1976-09

3.  Immune inflammation in newly developing facsimile synovia.

Authors:  Y M Sin; A D Sedgwick; D A Willoughby
Journal:  Int Arch Allergy Appl Immunol       Date:  1984

4.  Arachidonate metabolites in acute and chronic allergic air pouch inflammation in rats and the anti-inflammatory effects of indomethacin and dexamethasone.

Authors:  K Ohuchi; M Watanabe; L Levine
Journal:  Int Arch Allergy Appl Immunol       Date:  1984

5.  Leukotriene B4, polymorphonuclear leukocytes and inflammatory exudates in the rat.

Authors:  A W Ford-Hutchinson; G Brunet; P Savard; S Charleson
Journal:  Prostaglandins       Date:  1984-07

6.  A comparison of air pouch, sponge and pleurisy models of acute carrageenan inflammation in the rat.

Authors:  A D Sedgwick; P Lees
Journal:  Agents Actions       Date:  1986-06

7.  Studies into the influence of carrageenan-induced inflammation on articular cartilage degradation using implantation into air pouches.

Authors:  A D Sedgwick; A R Moore; A Y Al-Duaij; J C Edwards; D A Willoughby
Journal:  Br J Exp Pathol       Date:  1985-08

8.  The release of leukotriene B4 during experimental inflammation.

Authors:  P M Simmons; J A Salmon; S Moncada
Journal:  Biochem Pharmacol       Date:  1983-04-15       Impact factor: 5.858

9.  Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

Authors:  S B Mizel; J M Dayer; S M Krane; S E Mergenhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs.

Authors:  S Bombardieri; P Cattani; G Ciabattoni; O Di Munno; G Pasero; C Patrono; E Pinca; F Pugliese
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

View more
  15 in total

1.  Evaluation of antioxidative and anti-inflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation.

Authors:  Mandipika Jain; Hamendra Singh Parmar
Journal:  Inflamm Res       Date:  2010-12-23       Impact factor: 4.575

2.  Prostanoid release by macrophages at a distance from an inflammatory site.

Authors:  M Tissot; S Strzalko; A Thuret; J P Giroud
Journal:  Br J Exp Pathol       Date:  1989-10

3.  Changes in histamine and prostaglandins in acute inflammatory air pouch in mice.

Authors:  Y M Sin; C H Tan; S F Chan
Journal:  Agents Actions       Date:  1989-08

4.  Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition.

Authors:  K Brune; W S Beck; G Geisslinger; S Menzel-Soglowek; B M Peskar; B A Peskar
Journal:  Experientia       Date:  1991-03-15

Review 5.  Leukotriene B4 and inflammatory disease.

Authors:  R M McMillan; S J Foster
Journal:  Agents Actions       Date:  1988-06

6.  Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors.

Authors:  D Salvemini; P T Manning; B S Zweifel; K Seibert; J Connor; M G Currie; P Needleman; J L Masferrer
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  A combination of aspirin and gamma-tocopherol is superior to that of aspirin and alpha-tocopherol in anti-inflammatory action and attenuation of aspirin-induced adverse effects.

Authors:  Qing Jiang; Michelle Moreland; Bruce N Ames; Xinmin Yin
Journal:  J Nutr Biochem       Date:  2008-11-06       Impact factor: 6.048

8.  Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. I. Development and initial characterisation of the model.

Authors:  J Dawson; C Rordorf-Adam; T Geiger; H Towbin; S Kunz; H Nguyen; O Zingel; D Chaplin; K Vosbeck
Journal:  Agents Actions       Date:  1993-03

9.  Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Authors:  J L Masferrer; B S Zweifel; P T Manning; S D Hauser; K M Leahy; W G Smith; P C Isakson; K Seibert
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  Modulation of lymphocyte activating factor activity (interleukin 1 like activity) and acute phase proteins in pertussis-induced air pouch inflammation by muramyl dipeptide.

Authors:  A D Sedgwick; R E Hooke; P Lees; S A May
Journal:  Agents Actions       Date:  1987-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.